News | 2021

CoV-50 test to determine complications after Covid-19 disease is ready to use!

Based on the excellent results of the validation of the CoV-50 test on 327 Covid-19 patients in the Crit-CoV-U study, the BfArM issued a special approval according to Section 11 (1) MPG on December 30, 2020. On January 22nd, 2021, the regular approval of the DiaPat-CoV-50 test took place. These first study results were first provided on the LANCET Pre-Print Server on February 23, 2021. Since May 3rd, 2021, the accepted paper is published in the LANCET journal EClinicalMedicine.

This means that every doctor in Germany is entitled to carry out the CoV-50 test for the early molecular detection of the Covid-19 course in order to prevent a severe course in time.

Further information can be found here.